Loading…
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases
Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD...
Saved in:
Published in: | Stroke and vascular neurology 2022-07, Vol.7 (6), p.534-540 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3 |
---|---|
cites | cdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3 |
container_end_page | 540 |
container_issue | 6 |
container_start_page | 534 |
container_title | Stroke and vascular neurology |
container_volume | 7 |
creator | Pan, Yuesong Cai, Xueli Jing, Jing Wang, Suying Meng, Xia Mei, Lerong Yang, Yingying Jin, Aoming DongXiao, Yao Li, Shan Li, Hao Wei, Tiemin Wang, Yongjun Wang, Yilong |
description | Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448. |
doi_str_mv | 10.1136/svn-2022-001625 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_06d9e12e4a61448ca28b27fb89fc16bb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_06d9e12e4a61448ca28b27fb89fc16bb</doaj_id><sourcerecordid>2691787524</sourcerecordid><originalsourceid>FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</originalsourceid><addsrcrecordid>eNp9ks9rFDEUxwdRbKk9e5MBLxUZm9_zchFK_VUoeNFzyGRetlmykzWZXel_b-rU1Qp6ScLM532S9_g2zXNK3lDK1XnZTx0jjHWEUMXko-aYEak7UFo9PpwBjprTUtakQtD3muinzRGXICmn6rjx74L3mHGag42tLSW5YOeQptIm38awTducZgzTmX3VRtxjbL-H-aZ1tWbItSTavMLW5hnzbWunsS0bG2O7x1IqO4aCtmB51jzxNhY8vd9Pmq8f3n-5_NRdf_54dXlx3Q1S0rkD7IELTXumrZLMeU_syOsZPOHgUANRMDIJVEjLycihruCYVkIR4Sw_aa4W75js2mxz2Nh8a5IN5ueHlFemPjW4iIaoUSNlKKyiQoCzDAbW-wG0d1QNQ3W9XVzb3bDB0dUZ1YYfSB_-mcKNWaW90UCp1H0VnN0Lcvq2wzKbTSgOY7QTpl0xTNVOoZdMVPTlX-g67fJUR2VYL5WoAxH0v1R1SaoBeKXOF8rlVEpGf3gyJeYuOKYGx9wFxyzBqRUv_uz0wP-KSQVeL8CwWf--81-6H5Z7y4Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2691519883</pqid></control><display><type>article</type><title>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</title><source>BMJ Open Access Journals</source><source>PubMed Central</source><creator>Pan, Yuesong ; Cai, Xueli ; Jing, Jing ; Wang, Suying ; Meng, Xia ; Mei, Lerong ; Yang, Yingying ; Jin, Aoming ; DongXiao, Yao ; Li, Shan ; Li, Hao ; Wei, Tiemin ; Wang, Yongjun ; Wang, Yilong</creator><creatorcontrib>Pan, Yuesong ; Cai, Xueli ; Jing, Jing ; Wang, Suying ; Meng, Xia ; Mei, Lerong ; Yang, Yingying ; Jin, Aoming ; DongXiao, Yao ; Li, Shan ; Li, Hao ; Wei, Tiemin ; Wang, Yongjun ; Wang, Yilong</creatorcontrib><description>Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.</description><identifier>ISSN: 2059-8688</identifier><identifier>EISSN: 2059-8696</identifier><identifier>DOI: 10.1136/svn-2022-001625</identifier><identifier>PMID: 35851316</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Anticoagulants ; Antihypertensives ; Apolipoproteins ; Atherosclerosis ; Blood pressure ; Cerebrospinal fluid ; cerebrovascular disorders ; Cholesterol ; Cognitive ability ; Contraindications ; Data collection ; Diabetes ; Fasting ; Glucose ; Hypertension ; Investigations ; Lipoproteins ; Magnetic Resonance Imaging ; Medical imaging ; Neuroimaging ; Original Research ; plaque ; Regression analysis ; Reproducibility ; Veins & arteries</subject><ispartof>Stroke and vascular neurology, 2022-07, Vol.7 (6), p.534-540</ispartof><rights>Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</citedby><cites>FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</cites><orcidid>0000-0001-9431-9925 ; 0000-0002-3220-2382 ; 0000-0002-8591-4105 ; 0000-0003-3082-6789</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://svn.bmj.com/content/7/6/534.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://svn.bmj.com/content/7/6/534.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,55350,77660,77686</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35851316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Yuesong</creatorcontrib><creatorcontrib>Cai, Xueli</creatorcontrib><creatorcontrib>Jing, Jing</creatorcontrib><creatorcontrib>Wang, Suying</creatorcontrib><creatorcontrib>Meng, Xia</creatorcontrib><creatorcontrib>Mei, Lerong</creatorcontrib><creatorcontrib>Yang, Yingying</creatorcontrib><creatorcontrib>Jin, Aoming</creatorcontrib><creatorcontrib>DongXiao, Yao</creatorcontrib><creatorcontrib>Li, Shan</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Wei, Tiemin</creatorcontrib><creatorcontrib>Wang, Yongjun</creatorcontrib><creatorcontrib>Wang, Yilong</creatorcontrib><title>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</title><title>Stroke and vascular neurology</title><addtitle>Stroke Vasc Neurol</addtitle><addtitle>Stroke Vasc Neurol</addtitle><description>Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.</description><subject>Anticoagulants</subject><subject>Antihypertensives</subject><subject>Apolipoproteins</subject><subject>Atherosclerosis</subject><subject>Blood pressure</subject><subject>Cerebrospinal fluid</subject><subject>cerebrovascular disorders</subject><subject>Cholesterol</subject><subject>Cognitive ability</subject><subject>Contraindications</subject><subject>Data collection</subject><subject>Diabetes</subject><subject>Fasting</subject><subject>Glucose</subject><subject>Hypertension</subject><subject>Investigations</subject><subject>Lipoproteins</subject><subject>Magnetic Resonance Imaging</subject><subject>Medical imaging</subject><subject>Neuroimaging</subject><subject>Original Research</subject><subject>plaque</subject><subject>Regression analysis</subject><subject>Reproducibility</subject><subject>Veins & arteries</subject><issn>2059-8688</issn><issn>2059-8696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks9rFDEUxwdRbKk9e5MBLxUZm9_zchFK_VUoeNFzyGRetlmykzWZXel_b-rU1Qp6ScLM532S9_g2zXNK3lDK1XnZTx0jjHWEUMXko-aYEak7UFo9PpwBjprTUtakQtD3muinzRGXICmn6rjx74L3mHGag42tLSW5YOeQptIm38awTducZgzTmX3VRtxjbL-H-aZ1tWbItSTavMLW5hnzbWunsS0bG2O7x1IqO4aCtmB51jzxNhY8vd9Pmq8f3n-5_NRdf_54dXlx3Q1S0rkD7IELTXumrZLMeU_syOsZPOHgUANRMDIJVEjLycihruCYVkIR4Sw_aa4W75js2mxz2Nh8a5IN5ueHlFemPjW4iIaoUSNlKKyiQoCzDAbW-wG0d1QNQ3W9XVzb3bDB0dUZ1YYfSB_-mcKNWaW90UCp1H0VnN0Lcvq2wzKbTSgOY7QTpl0xTNVOoZdMVPTlX-g67fJUR2VYL5WoAxH0v1R1SaoBeKXOF8rlVEpGf3gyJeYuOKYGx9wFxyzBqRUv_uz0wP-KSQVeL8CwWf--81-6H5Z7y4Q</recordid><startdate>20220718</startdate><enddate>20220718</enddate><creator>Pan, Yuesong</creator><creator>Cai, Xueli</creator><creator>Jing, Jing</creator><creator>Wang, Suying</creator><creator>Meng, Xia</creator><creator>Mei, Lerong</creator><creator>Yang, Yingying</creator><creator>Jin, Aoming</creator><creator>DongXiao, Yao</creator><creator>Li, Shan</creator><creator>Li, Hao</creator><creator>Wei, Tiemin</creator><creator>Wang, Yongjun</creator><creator>Wang, Yilong</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9431-9925</orcidid><orcidid>https://orcid.org/0000-0002-3220-2382</orcidid><orcidid>https://orcid.org/0000-0002-8591-4105</orcidid><orcidid>https://orcid.org/0000-0003-3082-6789</orcidid></search><sort><creationdate>20220718</creationdate><title>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</title><author>Pan, Yuesong ; Cai, Xueli ; Jing, Jing ; Wang, Suying ; Meng, Xia ; Mei, Lerong ; Yang, Yingying ; Jin, Aoming ; DongXiao, Yao ; Li, Shan ; Li, Hao ; Wei, Tiemin ; Wang, Yongjun ; Wang, Yilong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants</topic><topic>Antihypertensives</topic><topic>Apolipoproteins</topic><topic>Atherosclerosis</topic><topic>Blood pressure</topic><topic>Cerebrospinal fluid</topic><topic>cerebrovascular disorders</topic><topic>Cholesterol</topic><topic>Cognitive ability</topic><topic>Contraindications</topic><topic>Data collection</topic><topic>Diabetes</topic><topic>Fasting</topic><topic>Glucose</topic><topic>Hypertension</topic><topic>Investigations</topic><topic>Lipoproteins</topic><topic>Magnetic Resonance Imaging</topic><topic>Medical imaging</topic><topic>Neuroimaging</topic><topic>Original Research</topic><topic>plaque</topic><topic>Regression analysis</topic><topic>Reproducibility</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Yuesong</creatorcontrib><creatorcontrib>Cai, Xueli</creatorcontrib><creatorcontrib>Jing, Jing</creatorcontrib><creatorcontrib>Wang, Suying</creatorcontrib><creatorcontrib>Meng, Xia</creatorcontrib><creatorcontrib>Mei, Lerong</creatorcontrib><creatorcontrib>Yang, Yingying</creatorcontrib><creatorcontrib>Jin, Aoming</creatorcontrib><creatorcontrib>DongXiao, Yao</creatorcontrib><creatorcontrib>Li, Shan</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Wei, Tiemin</creatorcontrib><creatorcontrib>Wang, Yongjun</creatorcontrib><creatorcontrib>Wang, Yilong</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Stroke and vascular neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Yuesong</au><au>Cai, Xueli</au><au>Jing, Jing</au><au>Wang, Suying</au><au>Meng, Xia</au><au>Mei, Lerong</au><au>Yang, Yingying</au><au>Jin, Aoming</au><au>DongXiao, Yao</au><au>Li, Shan</au><au>Li, Hao</au><au>Wei, Tiemin</au><au>Wang, Yongjun</au><au>Wang, Yilong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases</atitle><jtitle>Stroke and vascular neurology</jtitle><stitle>Stroke Vasc Neurol</stitle><addtitle>Stroke Vasc Neurol</addtitle><date>2022-07-18</date><risdate>2022</risdate><volume>7</volume><issue>6</issue><spage>534</spage><epage>540</epage><pages>534-540</pages><issn>2059-8688</issn><eissn>2059-8696</eissn><abstract>Background and purposeCerebral large artery and small vessel diseases are related to different pathogenetic mechanisms and have different risk factor profile. Lipoprotein(a) (Lp(a)) was shown to promote atherosclerosis but data was limited on its association with cerebral small vessel diseases (cSVD). The objective of this study was to assess the associations of Lp(a) level with the two types of cerebrovascular diseases.MethodsCommunity-dwelling subjects aged 50–75 years from the baseline survey of The PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events study were included. Lp(a) concentrations was measured and categorised into three groups according to the tertiles. Eligible participants were scanned by a 3.0T MRI scanner and assessed for intracranial atherosclerosis and cSVD burden based on four imaging markers.ResultsThis study included 3059 subjects. The average age of the participants was 61.2±6.7 years, and 53.5% (1636) were female. Compared with the first tertile, subjects with the second and third tertiles of Lp(a) concentrations were associated with an increased odds of presence of intracranial plaque (18.7% vs 15.4%, adj.OR 1.37, 95% CI 1.08 to 1.75; 18.9% vs 15.4%, adj.OR 1.34, 95% CI 1.05 to 1.72). Similar associations were observed for intracranial atherosclerotic burden. Whereas, subjects with the third tertile of Lp(a) level had a decreased odds of presence of cSVD (25.9% vs 31.7%, adj.OR 0.74, 95% CI 0.60 to 0.92) and lower cSVD burden (adj.cOR 0.76, 95% CI 0.62 to 0.94).ConclusionsIn this study, Lp(a) concentrations were positively associated with presence and burden of intracranial atherosclerosis, but was inversely associated with cSVD.Trial registration number NCT03178448.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>35851316</pmid><doi>10.1136/svn-2022-001625</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9431-9925</orcidid><orcidid>https://orcid.org/0000-0002-3220-2382</orcidid><orcidid>https://orcid.org/0000-0002-8591-4105</orcidid><orcidid>https://orcid.org/0000-0003-3082-6789</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2059-8688 |
ispartof | Stroke and vascular neurology, 2022-07, Vol.7 (6), p.534-540 |
issn | 2059-8688 2059-8696 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_06d9e12e4a61448ca28b27fb89fc16bb |
source | BMJ Open Access Journals; PubMed Central |
subjects | Anticoagulants Antihypertensives Apolipoproteins Atherosclerosis Blood pressure Cerebrospinal fluid cerebrovascular disorders Cholesterol Cognitive ability Contraindications Data collection Diabetes Fasting Glucose Hypertension Investigations Lipoproteins Magnetic Resonance Imaging Medical imaging Neuroimaging Original Research plaque Regression analysis Reproducibility Veins & arteries |
title | Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A12%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20associations%20of%20lipoprotein(a)%20level%20with%20cerebral%20large%20artery%20and%20small%20vessel%20diseases&rft.jtitle=Stroke%20and%20vascular%20neurology&rft.au=Pan,%20Yuesong&rft.date=2022-07-18&rft.volume=7&rft.issue=6&rft.spage=534&rft.epage=540&rft.pages=534-540&rft.issn=2059-8688&rft.eissn=2059-8696&rft_id=info:doi/10.1136/svn-2022-001625&rft_dat=%3Cproquest_doaj_%3E2691787524%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b551t-8e783491729a652cff0ad39a68f038ce98068d258145a30d38a308c2964604ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2691519883&rft_id=info:pmid/35851316&rfr_iscdi=true |